be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Final Report - analytica closes with record-breaking visitor attendance
The 26th analytica m...
MINICUBE PCR A NEW TOOL FOR GENETIC RESEARCH
The importance of research in our genes cannot ...
Bioeconomy drives Lodzkie. Americans are looking up to us
Close to a thousand participants, ...
Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidate
Pharnext Announces Positive Topline Results from Pivotal Phase 3 Trial of PXT3003 for Treatment of Charcot-Marie-Tooth Type 1A Disease

All articles

Filters:

Tag: radiopharmaceuticals

Show search box

2015-09-09

IASOcholine radiotracer export to the Czech Republic and Slovakia

IASOcholine radiotracer export to the Czech Republic and Slovakia

Synektik Group - a leading provider of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine - begins delivery of a special radiotracer, IASOcholine, to the Czech Republic and Slovakia. PET-CT imaging using Choline radiotracer is one of the most modern methods use... Read more

Tags cancer , radiopharmaceuticals , diagnostics

2013-12-02

Synektik SA enters a market worth $2,000,000,000

Synektik SA enters a market worth $2,000,000,000

Synektik SA – a leader in providing innovative products, services and IT solutions for diagnostic imaging and nuclear medicine signed the $4,000,000 contract for licenses and joint research and development with the Israel company Hadasit Medical Resarch & Development Ltd. On the basis of the agreeme... Read more

Tags collaboration , Synektik , radiopharmaceuticals , PET , cardiac diseases , Cezary Dariusz Kozanecki